nsv7095644
- Organism: Homo sapiens
- Study:nstd102 (Clinical Structural Variants)
- Variant Type:copy number variation
- Method Type:Multiple
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:1,000,878
- Description:NC_000019.9:g.(?_1456055)_(2456931_?)dup AND multiple conditions
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 5343 SVs from 99 studies. See in: genome view
Overlapping variant regions from other studies: 5343 SVs from 99 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv7095644 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000019.10 | Chr19 | 1,456,056 | 2,456,933 |
nsv7095644 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000019.9 | Chr19 | 1,456,055 | 2,456,931 |
Variant Call Information
Variant Call ID | Type | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv18787881 | duplication | Multiple | Multiple | EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9; Epilepsy, progressive myoclonic, 9; LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD; Lipodystrophy, partial, acquired, susceptibility to; Progressive myoclonic epilepsy type 9 | Uncertain significance | ClinVar | RCV003122897.2, VCV002427064.2 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv18787881 | Remapped | Perfect | NC_000019.10:g.(?_ 1456056)_(2456933_ ?)dup | GRCh38.p12 | First Pass | NC_000019.10 | Chr19 | 1,456,056 | 2,456,933 |
nssv18787881 | Submitted genomic | NC_000019.9:g.(?_1 456055)_(2456931_? )dup | GRCh37 (hg19) | NC_000019.9 | Chr19 | 1,456,055 | 2,456,931 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | HGVS | Type | Allele Origin | Subject Phenotype | Clinical Interpretation | Source of Interpretation | ClinVar ID |
---|---|---|---|---|---|---|---|
nssv18787881 | GRCh37: NC_000019.9:g.(?_1456055)_(2456931_?)dup | duplication | germline | EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9; Epilepsy, progressive myoclonic, 9; LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD; Lipodystrophy, partial, acquired, susceptibility to; Progressive myoclonic epilepsy type 9 | Uncertain significance | ClinVar | RCV003122897.2, VCV002427064.2 |